Your research timeline matters, and we work quickly to resolve any delivery issues
Denileukin diftitox (Ontak), approved by the FDA in 1999 against recurrent cutaneous T-cell lymphoma, is one of the first recombinant engineered chimeric proteins that combined interleukin-2 and diphtheria toxin
The fast-acting nature of injectables compared to oral alternatives makes them particularly suited to those with demanding training schedules who need reliable nutritional support
The peptide accelerates fiber regeneration and tendon repair by stimulating fibroblast activity and collagen synthesis at injury sites in the muscular system
Liu, M., Yuan, B., Jin, X., Zhu, M., Xu, H., Xie, G., et al., Front